ArticleCureus2026
Electroacupuncture as an Adjunctive Therapy for Bell's Palsy: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bell's palsy is the most common cause of acute unilateral lower motor neuron-type facial nerve paralysis and is generally managed with early administration of corticosteroids, with or without antiviral therapy. Although most patients experience substantial recovery, a clinically meaningful subset-including older adults, individuals with delayed presentation, and those with comorbid medical conditions-may be left with incomplete resolution, with persistent facial weakness, asymmetry, or synkinesis. Electroacupuncture (EA) has been proposed as an adjunctive treatment modality for facial nerve recovery, with hypothesized mechanisms including enhanced neuromuscular activation, improved regional blood flow, modulation of local inflammatory responses, and facilitation of peripheral nerve regeneration. However, robust clinical evidence and detailed case-based documentation remain limited. We report the case of an 81-year-old male patient who presented with acute left-sided lower motor neuron-type facial paralysis. The diagnosis was consistent with Bell's palsy, after a cerebrovascular accident was excluded, and neuroimaging demonstrated no acute intracranial pathology. An integrative treatment approach incorporating acupuncture with low-frequency electrical stimulation was initiated on day 17 post-onset, targeting facial and cranial acupoints. EA treatment was administered twice weekly for seven weeks and was supplemented with conservative home-based interventions. Facial nerve function improved from House-Brackmann Grade IV at presentation to Grade I-II. While this case suggests that EA may have a role as an adjunctive therapy in Bell's palsy, including in patients with delayed presentation and less favorable prognostic features, its interpretation is limited by the single-case design and the known potential for spontaneous recovery. Accordingly, controlled prospective studies are warranted to further evaluate the efficacy, optimal timing, and clinical utility of EA in the management of acute facial nerve paralysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.